{"id":5250,"date":"2023-10-17T13:16:35","date_gmt":"2023-10-17T05:16:35","guid":{"rendered":"https:\/\/www.ultimamarkets.com\/?p=5250"},"modified":"2025-07-16T08:06:59","modified_gmt":"2025-07-16T08:06:59","slug":"novo-nordisk-raises-outlook-on-popular-weight-loss-and-diabetes-drugs","status":"publish","type":"post","link":"https:\/\/www.ultimamarkets.com\/vn\/trade-news\/novo-nordisk-raises-outlook-on-popular-weight-loss-and-diabetes-drugs\/","title":{"rendered":"Novo Nordisk Prosperity: Wegovy and Ozempic In The Spotlight"},"content":{"rendered":"<div class=\"wp-block-post-date has-text-color has-black-color has-medium-font-size\"><time datetime=\"2023-10-17T13:16:35+00:00\"><a href=\"https:\/\/www.ultimamarkets.com\/vn\/trade-news\/novo-nordisk-raises-outlook-on-popular-weight-loss-and-diabetes-drugs\/\">Th\u00e1ng 10 17, 2023<\/a><\/time><\/div>\n\n\n<div style=\"color:#ddd\" class=\"wp-block-genesis-blocks-gb-spacer gb-block-spacer gb-divider-solid gb-divider-size-1\"><hr style=\"height:30px\" \/><\/div>\n\n\n\n<h1 class=\"wp-block-heading has-black-color has-text-color\"><strong>The Resilient Rise of Wegovy and Ozempic<\/strong><\/h1>\n\n\n\n<p class=\"has-medium-font-size\"><a href=\"https:\/\/www.google.com\/finance\/quote\/NVO:NYSE?sa=X&amp;ved=2ahUKEwjbzsPQuf6BAxUBSmwGHcdDBLQQ3ecFegQIahAh\" target=\"_blank\" rel=\"noopener nofollow\" title=\"Novo Nordisk's Share Price\">The Danish pharmaceutical company, Novo Nordisk (NVO)<\/a>, has recently updated its financial outlook for the year due to the increasing demand for its <a href=\"https:\/\/www.wegovy.com\/\" target=\"_blank\" rel=\"noopener nofollow\" title=\"Weight Loss Drug by Wegovy\">weight loss drug, Wegovy<\/a>, and <a href=\"https:\/\/www.ozempic.com\/\" target=\"_blank\" rel=\"noopener nofollow\" title=\"Diabetes Medication by Ozempic\">diabetes medication, Ozempic<\/a>. <\/p>\n\n\n\n<p class=\"has-medium-font-size\">These drugs are administered through weekly injections and have been sought after by patients for their significant weight loss effects.&nbsp;<\/p>\n\n\n\n<p class=\"has-medium-font-size\">These two medical innovations have taken the pharmaceutical world by storm, delivering remarkable results for patients who have long sought effective solutions for their health concerns.<\/p>\n\n\n\n<div style=\"color:#ddd\" class=\"wp-block-genesis-blocks-gb-spacer gb-block-spacer gb-divider-solid gb-divider-size-1\"><hr style=\"height:30px\" \/><\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Novo Nordisk Market Triumph<\/strong><\/h2>\n\n\n\n<p class=\"has-medium-font-size\">Novo Nordisk&#8217;s financial outlook for the year has seen a remarkable revision, reflecting the surging popularity of Wegovy and Ozempic. <\/p>\n\n\n\n<p class=\"has-medium-font-size\">As demand for these life-changing drugs continues to grow, the company is now anticipating a substantial boost in sales.<\/p>\n\n\n\n<p class=\"has-medium-font-size\">Novo Nordisk&#8217;s revised forecast suggests a growth in sales between 32% to 38%, up from the previous estimate of 27% to 33%. <\/p>\n\n\n\n<p class=\"has-medium-font-size\">The company also anticipates an operating profit growth of 40% to 46%, an increase from the earlier prediction of 31% to 37%. <\/p>\n\n\n\n<p class=\"has-medium-font-size\">It&#8217;s evident that Novo Nordisk&#8217;s optimistic outlook is fueled by the unanticipated success of Ozempic, particularly in the U.S. market.<\/p>\n\n\n\n<div style=\"color:#ddd\" class=\"wp-block-genesis-blocks-gb-spacer gb-block-spacer gb-divider-solid gb-divider-size-1\"><hr style=\"height:30px\" \/><\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><strong><strong>Novo Nordisk&#8217;s<\/strong> Stock Hit YTD High<\/strong>&nbsp;<\/h2>\n\n\n\n<p class=\"has-medium-font-size\">The popularity of Wegovy and Ozempic has propelled Novo Nordisk to become Europe&#8217;s most valuable company. The company&#8217;s U.S.-listed shares (ADR) also saw a new high for the year. <\/p>\n\n\n\n<p class=\"has-medium-font-size\">This exceptional market performance is a testament to the company&#8217;s unwavering commitment to improving the health and well-being of individuals around the world. <\/p>\n\n\n\n<p class=\"has-medium-font-size\">The market is keenly awaiting Novo Nordisk&#8217;s third-quarter earnings report, scheduled for release on November 2nd, which is expected to underscore the company&#8217;s impressive growth trajectory.<\/p>\n\n\n\n<div style=\"color:#ddd\" class=\"wp-block-genesis-blocks-gb-spacer gb-block-spacer gb-divider-solid gb-divider-size-1\"><hr style=\"height:30px\" \/><\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Strategic US$1.3B Acquisition: Ocedurenone<\/strong><\/h2>\n\n\n\n<p class=\"has-medium-font-size\">In a strategic move to further expand its portfolio and contribute to improved healthcare, Novo Nordisk has made a substantial acquisition.<\/p>\n\n\n\n<p class=\"has-medium-font-size\">Novo Nordisk has decided to buy the new drug called <a href=\"https:\/\/www.novonordisk.com\/news-and-media\/news-and-ir-materials\/news-details.html?id=166329\" target=\"_blank\" rel=\"noopener nofollow\" title=\"Read More about this New Drug KBP Biosciences\">Ocedurenone<\/a> for $1.3 billion from KBP Biosciences. The drug can help people with high blood pressure that is hard to control. <\/p>\n\n\n\n<p class=\"has-medium-font-size\">This acquisition, set to be finalized by the end of 2023, is anticipated to be a game-changer in the field of cardiovascular health. Importantly, it&#8217;s worth noting that this acquisition is not expected to affect Novo Nordisk&#8217;s overall profit for the year, ensuring that the company&#8217;s financial stability remains intact.<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full\"><img decoding=\"async\" src=\"https:\/\/www.ultimamarkets.com\/wp-content\/uploads\/2023\/10\/1-1-1.png\" alt=\"Novo Nordisk ADR YTD Chart\u00a0By Ultima Markets MT4\" class=\"wp-image-5251\" \/><\/figure><\/div>\n\n\n<p class=\"has-text-align-center has-small-font-size\"><em>(Novo Nordisk ADR YTD Chart)&nbsp;<\/em><\/p>\n\n\n\n<p class=\"has-medium-font-size\">Novo Nordisk&#8217;s continuous commitment to pioneering medical breakthroughs, coupled with its exceptional market performance, solidifies its position as a key player in the pharmaceutical industry. <\/p>\n\n\n\n<p class=\"has-medium-font-size\">The company&#8217;s unwavering dedication to improving patients&#8217; lives is reflected in their outstanding financial results and their strategic acquisitions, setting the stage for a promising future in healthcare.<\/p>\n\n\n\n<div style=\"color:#ddd\" class=\"wp-block-genesis-blocks-gb-spacer gb-block-spacer gb-divider-solid gb-divider-size-1\"><hr style=\"height:30px\" \/><\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Novo Nordisk Transformative Impact<\/strong><\/h2>\n\n\n\n<p class=\"has-medium-font-size\">In conclusion, Novo Nordisk&#8217;s success story is a testament to the transformative impact of Wegovy and Ozempic.<\/p>\n\n\n\n<p class=\"has-medium-font-size\">Their upwardly revised financial forecast, soaring stock performance, and strategic acquisitions are all indicators of a company that&#8217;s dedicated to making a meaningful difference in the lives of people worldwide. <\/p>\n\n\n\n<p class=\"has-medium-font-size\">As Novo Nordisk continues to innovate and meet the ever-growing healthcare needs of the population, its future prospects appear exceedingly bright.<\/p>\n\n\n\n<div style=\"color:#ddd\" class=\"wp-block-genesis-blocks-gb-spacer gb-block-spacer gb-divider-solid gb-divider-size-1\"><hr style=\"height:30px\" \/><\/div>\n\n\n\n<p class=\"has-medium-font-size\">For the latest news and updates, delve deeper into our articles.<\/p>\n\n\n\n\n\n<div style=\"color:#ddd\" class=\"wp-block-genesis-blocks-gb-spacer gb-block-spacer gb-divider-solid gb-divider-size-1\"><hr style=\"height:30px\" \/><\/div>\n\n\n","protected":false},"excerpt":{"rendered":"<p>The Resilient Rise of Wegovy and Ozempic The Danish pharmaceutical company, Novo Nordisk (NVO), has recently updated its financial outlook for the year due to the increasing demand for its weight loss drug, Wegovy, and diabetes medication, Ozempic. These drugs are administered through weekly injections and have been sought after by patients for their significant [&hellip;]<\/p>\n","protected":false},"author":13,"featured_media":5252,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[239],"tags":[157],"class_list":["post-5250","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-trade-news","tag-novo-nordisk"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Novo Nordisk Prosperity: Wegovy and Ozempic In The Spotlight | Ultima Markets<\/title>\n<meta name=\"description\" content=\"The Resilient Rise of Wegovy and Ozempic The Danish pharmaceutical company, Novo Nordisk (NVO), has recently updated its financial outlook for the year\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"vi_VN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novo Nordisk Prosperity: Wegovy and Ozempic In The Spotlight\" \/>\n<meta property=\"og:description\" content=\"The Resilient Rise of Wegovy and Ozempic The Danish pharmaceutical company, Novo Nordisk (NVO), has recently updated its financial outlook for the year\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ultimamarkets.com\/vn\/wp-json\/wp\/v2\/posts\/5250\" \/>\n<meta property=\"og:site_name\" content=\"Ultima Markets\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ultimamarketsglobal\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-17T05:16:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-16T08:06:59+00:00\" \/>\n<meta name=\"author\" content=\"mervin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@UltimaMarkets\" \/>\n<meta name=\"twitter:site\" content=\"@UltimaMarkets\" \/>\n<meta name=\"twitter:label1\" content=\"\u0110\u01b0\u1ee3c vi\u1ebft b\u1edfi\" \/>\n\t<meta name=\"twitter:data1\" content=\"mervin\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u01af\u1edbc t\u00ednh th\u1eddi gian \u0111\u1ecdc\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 ph\u00fat\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.ultimamarkets.com\\\/vn\\\/trade-news\\\/novo-nordisk-raises-outlook-on-popular-weight-loss-and-diabetes-drugs\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ultimamarkets.com\\\/vn\\\/trade-news\\\/novo-nordisk-raises-outlook-on-popular-weight-loss-and-diabetes-drugs\\\/\"},\"author\":{\"name\":\"mervin\",\"@id\":\"https:\\\/\\\/www.ultimamarkets.com\\\/vn\\\/#\\\/schema\\\/person\\\/acd24ecc8c3b66996759943157711472\"},\"headline\":\"Novo Nordisk Prosperity: Wegovy and Ozempic In The Spotlight\",\"datePublished\":\"2023-10-17T05:16:35+00:00\",\"dateModified\":\"2025-07-16T08:06:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.ultimamarkets.com\\\/vn\\\/trade-news\\\/novo-nordisk-raises-outlook-on-popular-weight-loss-and-diabetes-drugs\\\/\"},\"wordCount\":545,\"publisher\":{\"@id\":\"https:\\\/\\\/www.ultimamarkets.com\\\/vn\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ultimamarkets.com\\\/vn\\\/trade-news\\\/novo-nordisk-raises-outlook-on-popular-weight-loss-and-diabetes-drugs\\\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"Novo Nordisk\"],\"articleSection\":[\"Trade News\"],\"inLanguage\":\"vi\"},{\"@type\":\"WebPage\",\"@id\":\"\",\"url\":\"https:\\\/\\\/www.ultimamarkets.com\\\/vn\\\/wp-json\\\/wp\\\/v2\\\/posts\\\/5250\",\"name\":\"Novo Nordisk Prosperity: Wegovy and Ozempic In The Spotlight | Ultima Markets\",\"thumbnailUrl\":\"\",\"datePublished\":\"2023-10-17T05:16:35+00:00\",\"dateModified\":\"2025-07-16T08:06:59+00:00\",\"description\":\"The Resilient Rise of Wegovy and Ozempic The Danish pharmaceutical company, Novo Nordisk (NVO), has recently updated its financial outlook for the year\",\"inLanguage\":\"vi\"},{\"@type\":\"ImageObject\",\"inLanguage\":\"vi\",\"@id\":\"https:\\\/\\\/www.ultimamarkets.com\\\/vn\\\/trade-news\\\/novo-nordisk-raises-outlook-on-popular-weight-loss-and-diabetes-drugs\\\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ultimamarkets.com\\\/vn\\\/#organization\",\"name\":\"Ultima Markets\",\"alternateName\":\"UM\",\"url\":\"https:\\\/\\\/www.ultimamarkets.com\\\/vn\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vi\",\"@id\":\"https:\\\/\\\/www.ultimamarkets.com\\\/vn\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ultimamarkets.com\\\/vn\\\/wp-content\\\/uploads\\\/sites\\\/16\\\/2025\\\/12\\\/ultima-logo-ori-color-1.png\",\"contentUrl\":\"https:\\\/\\\/www.ultimamarkets.com\\\/vn\\\/wp-content\\\/uploads\\\/sites\\\/16\\\/2025\\\/12\\\/ultima-logo-ori-color-1.png\",\"width\":1392,\"height\":1392,\"caption\":\"Ultima Markets\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ultimamarkets.com\\\/vn\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ultimamarketsglobal\",\"https:\\\/\\\/x.com\\\/UltimaMarkets\",\"https:\\\/\\\/www.instagram.com\\\/ultima_markets\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ultima-markets\\\/\",\"https:\\\/\\\/www.tiktok.com\\\/@ultimamarkets_global\",\"https:\\\/\\\/www.youtube.com\\\/@ultima_markets\",\"https:\\\/\\\/t.me\\\/ultimamarkets_official\"],\"description\":\"Ultima Markets l\u00e0 m\u1ed9t nh\u00e0 m\u00f4i gi\u1edbi \u0111a t\u00e0i s\u1ea3n to\u00e0n c\u1ea7u, cung c\u1ea5p d\u1ecbch v\u1ee5 giao d\u1ecbch Forex, Kim lo\u1ea1i, H\u00e0ng h\u00f3a, Ch\u1ec9 s\u1ed1 v\u00e0 CFD. C\u00f4ng ty mang \u0111\u1ebfn ph\u00e2n t\u00edch th\u1ecb tr\u01b0\u1eddng, t\u00e0i nguy\u00ean gi\u00e1o d\u1ee5c v\u00e0 c\u00e1c c\u00f4ng c\u1ee5 giao d\u1ecbch ti\u00ean ti\u1ebfn, \u0111\u01b0\u1ee3c thi\u1ebft k\u1ebf \u0111\u1ec3 h\u1ed7 tr\u1ee3 nh\u00e0 giao d\u1ecbch \u1edf m\u1ecdi c\u1ea5p \u0111\u1ed9 kinh nghi\u1ec7m. Ultima Markets cam k\u1ebft minh b\u1ea1ch, l\u1ea5y kh\u00e1ch h\u00e0ng l\u00e0m tr\u1ecdng t\u00e2m v\u00e0 duy tr\u00ec c\u00e1c ti\u00eau chu\u1ea9n v\u1eadn h\u00e0nh cao tr\u00ean th\u1ecb tr\u01b0\u1eddng t\u00e0i ch\u00ednh.\",\"email\":\"support@ultimamarkets.com\",\"legalName\":\"Ultima Markets Pte Ltd\",\"foundingDate\":\"2016-06-08\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":\"201\",\"maxValue\":\"500\"}},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ultimamarkets.com\\\/vn\\\/wp-json\\\/wp\\\/v2\\\/posts\\\/5250#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.ultimamarkets.com\\\/vn\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"posts\",\"item\":\"https:\\\/\\\/www.ultimamarkets.com\\\/vn\\\/wp-json\\\/wp\\\/v2\\\/posts\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Novo Nordisk Prosperity: Wegovy and Ozempic In The Spotlight\",\"item\":\"https:\\\/\\\/www.ultimamarkets.com\\\/vn\\\/wp-json\\\/wp\\\/v2\\\/posts\\\/5250\"}]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Novo Nordisk Prosperity: Wegovy and Ozempic In The Spotlight | Ultima Markets","description":"The Resilient Rise of Wegovy and Ozempic The Danish pharmaceutical company, Novo Nordisk (NVO), has recently updated its financial outlook for the year","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"vi_VN","og_type":"article","og_title":"Novo Nordisk Prosperity: Wegovy and Ozempic In The Spotlight","og_description":"The Resilient Rise of Wegovy and Ozempic The Danish pharmaceutical company, Novo Nordisk (NVO), has recently updated its financial outlook for the year","og_url":"https:\/\/www.ultimamarkets.com\/vn\/wp-json\/wp\/v2\/posts\/5250","og_site_name":"Ultima Markets","article_publisher":"https:\/\/www.facebook.com\/ultimamarketsglobal","article_published_time":"2023-10-17T05:16:35+00:00","article_modified_time":"2025-07-16T08:06:59+00:00","author":"mervin","twitter_card":"summary_large_image","twitter_creator":"@UltimaMarkets","twitter_site":"@UltimaMarkets","twitter_misc":{"\u0110\u01b0\u1ee3c vi\u1ebft b\u1edfi":"mervin","\u01af\u1edbc t\u00ednh th\u1eddi gian \u0111\u1ecdc":"3 ph\u00fat"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ultimamarkets.com\/vn\/trade-news\/novo-nordisk-raises-outlook-on-popular-weight-loss-and-diabetes-drugs\/#article","isPartOf":{"@id":"https:\/\/www.ultimamarkets.com\/vn\/trade-news\/novo-nordisk-raises-outlook-on-popular-weight-loss-and-diabetes-drugs\/"},"author":{"name":"mervin","@id":"https:\/\/www.ultimamarkets.com\/vn\/#\/schema\/person\/acd24ecc8c3b66996759943157711472"},"headline":"Novo Nordisk Prosperity: Wegovy and Ozempic In The Spotlight","datePublished":"2023-10-17T05:16:35+00:00","dateModified":"2025-07-16T08:06:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ultimamarkets.com\/vn\/trade-news\/novo-nordisk-raises-outlook-on-popular-weight-loss-and-diabetes-drugs\/"},"wordCount":545,"publisher":{"@id":"https:\/\/www.ultimamarkets.com\/vn\/#organization"},"image":{"@id":"https:\/\/www.ultimamarkets.com\/vn\/trade-news\/novo-nordisk-raises-outlook-on-popular-weight-loss-and-diabetes-drugs\/#primaryimage"},"thumbnailUrl":"","keywords":["Novo Nordisk"],"articleSection":["Trade News"],"inLanguage":"vi"},{"@type":"WebPage","@id":"","url":"https:\/\/www.ultimamarkets.com\/vn\/wp-json\/wp\/v2\/posts\/5250","name":"Novo Nordisk Prosperity: Wegovy and Ozempic In The Spotlight | Ultima Markets","thumbnailUrl":"","datePublished":"2023-10-17T05:16:35+00:00","dateModified":"2025-07-16T08:06:59+00:00","description":"The Resilient Rise of Wegovy and Ozempic The Danish pharmaceutical company, Novo Nordisk (NVO), has recently updated its financial outlook for the year","inLanguage":"vi"},{"@type":"ImageObject","inLanguage":"vi","@id":"https:\/\/www.ultimamarkets.com\/vn\/trade-news\/novo-nordisk-raises-outlook-on-popular-weight-loss-and-diabetes-drugs\/#primaryimage","url":"","contentUrl":""},{"@type":"Organization","@id":"https:\/\/www.ultimamarkets.com\/vn\/#organization","name":"Ultima Markets","alternateName":"UM","url":"https:\/\/www.ultimamarkets.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"vi","@id":"https:\/\/www.ultimamarkets.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/www.ultimamarkets.com\/vn\/wp-content\/uploads\/sites\/16\/2025\/12\/ultima-logo-ori-color-1.png","contentUrl":"https:\/\/www.ultimamarkets.com\/vn\/wp-content\/uploads\/sites\/16\/2025\/12\/ultima-logo-ori-color-1.png","width":1392,"height":1392,"caption":"Ultima Markets"},"image":{"@id":"https:\/\/www.ultimamarkets.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ultimamarketsglobal","https:\/\/x.com\/UltimaMarkets","https:\/\/www.instagram.com\/ultima_markets\/","https:\/\/www.linkedin.com\/company\/ultima-markets\/","https:\/\/www.tiktok.com\/@ultimamarkets_global","https:\/\/www.youtube.com\/@ultima_markets","https:\/\/t.me\/ultimamarkets_official"],"description":"Ultima Markets l\u00e0 m\u1ed9t nh\u00e0 m\u00f4i gi\u1edbi \u0111a t\u00e0i s\u1ea3n to\u00e0n c\u1ea7u, cung c\u1ea5p d\u1ecbch v\u1ee5 giao d\u1ecbch Forex, Kim lo\u1ea1i, H\u00e0ng h\u00f3a, Ch\u1ec9 s\u1ed1 v\u00e0 CFD. C\u00f4ng ty mang \u0111\u1ebfn ph\u00e2n t\u00edch th\u1ecb tr\u01b0\u1eddng, t\u00e0i nguy\u00ean gi\u00e1o d\u1ee5c v\u00e0 c\u00e1c c\u00f4ng c\u1ee5 giao d\u1ecbch ti\u00ean ti\u1ebfn, \u0111\u01b0\u1ee3c thi\u1ebft k\u1ebf \u0111\u1ec3 h\u1ed7 tr\u1ee3 nh\u00e0 giao d\u1ecbch \u1edf m\u1ecdi c\u1ea5p \u0111\u1ed9 kinh nghi\u1ec7m. Ultima Markets cam k\u1ebft minh b\u1ea1ch, l\u1ea5y kh\u00e1ch h\u00e0ng l\u00e0m tr\u1ecdng t\u00e2m v\u00e0 duy tr\u00ec c\u00e1c ti\u00eau chu\u1ea9n v\u1eadn h\u00e0nh cao tr\u00ean th\u1ecb tr\u01b0\u1eddng t\u00e0i ch\u00ednh.","email":"support@ultimamarkets.com","legalName":"Ultima Markets Pte Ltd","foundingDate":"2016-06-08","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"201","maxValue":"500"}},{"@type":"BreadcrumbList","@id":"https:\/\/www.ultimamarkets.com\/vn\/wp-json\/wp\/v2\/posts\/5250#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ultimamarkets.com\/vn"},{"@type":"ListItem","position":2,"name":"posts","item":"https:\/\/www.ultimamarkets.com\/vn\/wp-json\/wp\/v2\/posts"},{"@type":"ListItem","position":3,"name":"Novo Nordisk Prosperity: Wegovy and Ozempic In The Spotlight","item":"https:\/\/www.ultimamarkets.com\/vn\/wp-json\/wp\/v2\/posts\/5250"}]}]}},"_links":{"self":[{"href":"https:\/\/www.ultimamarkets.com\/vn\/wp-json\/wp\/v2\/posts\/5250","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ultimamarkets.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ultimamarkets.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ultimamarkets.com\/vn\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ultimamarkets.com\/vn\/wp-json\/wp\/v2\/comments?post=5250"}],"version-history":[{"count":0,"href":"https:\/\/www.ultimamarkets.com\/vn\/wp-json\/wp\/v2\/posts\/5250\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ultimamarkets.com\/vn\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.ultimamarkets.com\/vn\/wp-json\/wp\/v2\/media?parent=5250"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ultimamarkets.com\/vn\/wp-json\/wp\/v2\/categories?post=5250"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ultimamarkets.com\/vn\/wp-json\/wp\/v2\/tags?post=5250"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}